130 related articles for article (PubMed ID: 29238267)
1. Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells.
Qin Y; Sekine I; Fan M; Takiguchi Y; Tada Y; Shingyoji M; Hanazono M; Yamaguchi N; Tagawa M
Cancer Cell Int; 2017; 17():120. PubMed ID: 29238267
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation induced in pemetrexed-treated cells is associated with development of drug resistance independently of target enzyme expression.
Qin Y; Sekine I; Hanazono M; Morinaga T; Fan M; Takiguchi Y; Tada Y; Shingyoji M; Yamaguchi N; Tagawa M
Mol Oncol; 2019 Jun; 13(6):1419-1432. PubMed ID: 31033201
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines.
Monica V; Lo Iacono M; Bracco E; Busso S; Di Blasio L; Primo L; Peracino B; Papotti M; Scagliotti G
Oncotarget; 2016 Nov; 7(47):76577-76589. PubMed ID: 27391433
[TBL] [Abstract][Full Text] [Related]
4. Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.
Shimazu K; Tada Y; Morinaga T; Shingyoji M; Sekine I; Shimada H; Hiroshima K; Namiki T; Tatsumi K; Tagawa M
BMC Cancer; 2017 May; 17(1):309. PubMed ID: 28464864
[TBL] [Abstract][Full Text] [Related]
5. The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.
Ding X; Gu Y; Jin M; Guo X; Xue S; Tan C; Huang J; Yang W; Xue M; Zhou Q; Wang W; Zhang Y
Theranostics; 2020; 10(13):6048-6060. PubMed ID: 32483437
[No Abstract] [Full Text] [Related]
6. Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.
Zhang D; Ochi N; Takigawa N; Tanimoto Y; Chen Y; Ichihara E; Hotta K; Tabata M; Tanimoto M; Kiura K
Cancer Lett; 2011 Oct; 309(2):228-35. PubMed ID: 21742432
[TBL] [Abstract][Full Text] [Related]
7. Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed.
Takeuchi S; Seike M; Noro R; Soeno C; Sugano T; Zou F; Uesaka H; Nishijima N; Matsumoto M; Minegishi Y; Kubota K; Gemma A
Int J Oncol; 2014 Jun; 44(6):1886-94. PubMed ID: 24714722
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide (NO) enhances pemetrexed cytotoxicity via NO‑cGMP signaling in lung adenocarcinoma cells in vitro and in vivo.
Nagai H; Yasuda H; Hatachi Y; Xue D; Sasaki T; Yamaya M; Sakamori Y; Togashi Y; Masago K; Ito I; Kim YH; Mio T; Mishima M
Int J Oncol; 2012 Jul; 41(1):24-30. PubMed ID: 22552400
[TBL] [Abstract][Full Text] [Related]
9. Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed.
Li Q; Kawamura K; Yamanaka M; Okamoto S; Yang S; Yamauchi S; Fukamachi T; Kobayashi H; Tada Y; Takiguchi Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
Cancer Gene Ther; 2012 Mar; 19(3):218-28. PubMed ID: 22223137
[TBL] [Abstract][Full Text] [Related]
10. High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase.
Kuo WT; Tu DG; Chiu LY; Sheu GT; Wu MF
Oncol Rep; 2017 Nov; 38(5):2787-2795. PubMed ID: 28901493
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone alleviates pemetrexed-induced senescence in Non-Small-Cell Lung Cancer.
Ge H; Ke J; Xu N; Li H; Gong J; Li X; Song Y; Zhu H; Bai C
Food Chem Toxicol; 2018 Sep; 119():86-97. PubMed ID: 29753869
[TBL] [Abstract][Full Text] [Related]
12. Effect of renal function on pemetrexed-induced haematotoxicity.
Ando Y; Hayashi T; Ujita M; Murai S; Ohta H; Ito K; Yamaguchi T; Funatsu M; Ikeda Y; Imaizumi K; Kawada K; Yasuda K; Yamada S
Cancer Chemother Pharmacol; 2016 Jul; 78(1):183-9. PubMed ID: 27286996
[TBL] [Abstract][Full Text] [Related]
13. Significance of thymidylate synthase expression for resistance to pemetrexed in pulmonary adenocarcinoma.
Yang M; Fan WF; Pu XL; Liu FY; Meng LJ; Wang J
Oncol Lett; 2014 Jan; 7(1):227-232. PubMed ID: 24348854
[TBL] [Abstract][Full Text] [Related]
14. Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma.
Lustgarten DE; Deshpande C; Aggarwal C; Wang LC; Saloura V; Vachani A; Wang LP; Litzky L; Feldman M; Creaney J; Nowak AK; Langer C; Inghilleri S; Stella G; Albelda SM
J Thorac Oncol; 2013 Apr; 8(4):469-77. PubMed ID: 23486267
[TBL] [Abstract][Full Text] [Related]
15. Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.
Tanino R; Tsubata Y; Harashima N; Harada M; Isobe T
Oncotarget; 2018 Mar; 9(24):16807-16821. PubMed ID: 29682186
[TBL] [Abstract][Full Text] [Related]
16. 2-Deoxy-glucose Enhances the Effect of Cisplatin and Pemetrexed in Reducing Malignant Pleural Mesothelioma Cell Proliferation But Not Spheroid Growth.
Gerogianni I; Pitaraki E; Jagirdar RM; Kouliou O; Giannakou L; Giannopoulos S; Papazoglou E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Anticancer Res; 2019 Jul; 39(7):3809-3814. PubMed ID: 31262908
[TBL] [Abstract][Full Text] [Related]
17. Identification of Up- and Down-Regulated Proteins in Pemetrexed-Resistant Human Lung Adenocarcinoma: Flavin Reductase and Calreticulin Play Key Roles in the Development of Pemetrexed-Associated Resistance.
Chou HC; Chen JY; Lin DY; Wen YF; Lin CC; Lin SH; Lin CH; Chung TW; Liao EC; Chen YJ; Wei YS; Tsai YT; Chan HL
J Proteome Res; 2015 Nov; 14(11):4907-20. PubMed ID: 26452990
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of both EGFR and ErbB3 improves the cellular response to pemetrexed in an established pemetrexed‑resistant lung adenocarcinoma A549 cell line.
Yu Z; Li XM; Liu SH; Liu B; Gao CH; Hou X
Oncol Rep; 2014 Apr; 31(4):1818-24. PubMed ID: 24549863
[TBL] [Abstract][Full Text] [Related]
19. Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma.
Røe OD; Szulkin A; Anderssen E; Flatberg A; Sandeck H; Amundsen T; Erlandsen SE; Dobra K; Sundstrøm SH
PLoS One; 2012; 7(8):e40521. PubMed ID: 22905093
[TBL] [Abstract][Full Text] [Related]
20. MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma.
Yamamoto K; Seike M; Takeuchi S; Soeno C; Miyanaga A; Noro R; Minegishi Y; Kubota K; Gemma A
Oncol Rep; 2014 Dec; 32(6):2365-72. PubMed ID: 25231602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]